Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 27, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - June 27, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 100     Next >>     Go To Page:

6/20/17 - Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT? (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old
Neos Therapeutics, Inc., a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary modified-release drug delivery and orally disintegrating tablet technologies, today announced that the U.S. Food and Drug Administration approved Cotempla XR-ODT, the first and only.
6/19/17 - Summit Biosciences Announces the Addition of Ted A. Marcuccio to its Senior Management Team
By a News Reporter-Staff News Editor at Pharma Business Week Summit Biosciences Inc. announced that Ted A. Marcuccio has been appointed Chief Business Officer. Most recently, Mr. Marcuccio led government and commercial development and alliance management for Meridian Medical Technologies, Inc., a subsidiary of Pfizer Inc., which specialized in em
6/19/17 - The dos, donts of flu self-medication [Cape Community (South Africa)]
Nicole Jennings, spokesperson for Pharma Dynamics- a local pharmaceutical company- said despite negative connotations generally associated with the idea of self-medication, it was fast becoming the most popular method of self-care for the majority. More than 80% of pharmacists from Joburg, Cape Town and Durban participating in a poll they had condu
6/19/17 - What's up, doc? Allergist spotlights immunotherapy and allergen basics hammer
Margaret Sigman is with Advanced Allergy and Asthma of Virginia. This type of immunotherapy is available for grass pollen and ragweed pollen allergies, and the FDA recently approved SLIT for house dust mites. SLIT also is being closely studied to treat food allergies, but so far no treatment has been FDA- approved.
6/18/17 - Acetaminophen can be deadly if not taken correctly
A fairly toxic drug is probably lurking in your medicine cabinet. Acetaminophen is the No. 1 cause of acute liver failure in the United States. William M. Lee, professor of internal medicine at University of Texas Southwestern Medical Center in Dallas and the principal investigator for the Acute Liver Failure Study Group.
6/18/17 - What not to do when you have the flu [Cape Community (South Africa)]
Nicole Jennings, spokesperson for Pharma Dynamics a local pharmaceutical company said despite negative connotations generally associated with the idea of self-medication, it was fast becoming the most popular method of self-care for the majority of South Africans. With over 80% of pharmacists from Johannesburg, Cape Town and Durban participat
6/18/17 - What not to do when you have the flu [Cape Times (South Africa)]
Nicole Jennings, spokesperson for Pharma Dynamics a local pharmaceutical company said despite negative connotations generally associated with the idea of self-medication, it was fast becoming the most popular method of self-care for the majority of South Africans. With over 80% of pharmacists from Johannesburg, Cape Town and Durban participat
6/17/17 - Drugmaker paying $33M over recalled nonprescription meds [Malta Independent, The]
Johnson& Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold nonprescription medicines that didn't meet federal quality requirements. The case dates to 2009, when Johnson& Johnson began dozens of voluntary recalls of popular over-the-counter medicines for children and adults, including Tylen
6/17/17 - Gala Global Inc. Names Dr. Maqsood Rehman as COO [National News Agency (Lebanon)]
Dr. Rehman comes to Gala Global from doing work as a global soybean breeding leader for Dow AgroSciences, Indianapolis, Ind.. Dr. Rehman will be leading Gala Globals development team working to commercialize digital plant cloning incubators from Controlled Environment Genomics, Inc., an Akron, Ohio- based genomics company recently acquired by Gala
6/16/17 - Allergic Rhinitis Market is rising significantly and is expected to grow by the CAGR of 7% during 2017-2023
Major Key Players are Merck, GSK, Sanofi, Cigna, Himalaya, J&J, Chong kun Dang Pharmaceutical Corp., Faes, Farma, Glenmark Pharmaceutical " Market Research Future PUNE, MAHARASHTRA, INDIA, June 16, 2017/ EINPresswire.com/ Market Highlights Hay fever is another name for allergic rhinitis which is a nose related disease. The sale for anti-allergi
6/16/17 - CBO Issues Cost Estimate for FDA Reauthorization Act
*Reauthorize certain programs and grants administered by FDA and the National Institutes of Health,. *Require the Government Accountability Office to report on FDA and NIH. Implementing S. 934 would require increased funding for a variety of FDA activities, but most of the increase in FDA spending would be offset by additional fees that would be co
6/16/17 - District Court Enters Permanent Injunction Against Florida and New Jersey Companies and Senior Managers to Stop the Distribution of Unapproved, Misbranded, and Adulterated Drugs
The U.S. District Court for the Southern District of Florida entered a consent decree of permanent injunction against Stratus Pharmaceuticals Inc. of Miami, Florida; Sonar Products Inc. of Carlstadt, New Jersey; and individuals Alberto Hoyo and Juan Carlos Billoch, the Department of Justice announced today. The complaint alleges, among other things
6/16/17 - District Court Enters Permanent Injunction Against Florida and New Jersey Companies and Senior Managers to Stop the Distribution of Unapproved, Misbranded, and Adulterated Drugs [Qatar News Agency]
The U.S. District Court for the Southern District of Florida entered a consent decree of permanent injunction against Stratus Pharmaceuticals Inc. of Miami, Florida; Sonar Products Inc. of Carlstadt, New Jersey; and individuals Alberto Hoyo and Juan Carlos Billoch, the Department of Justice announced today. The complaint alleges, among other things
6/16/17 - Gala Global Inc. Names Dr. Maqsood Rehman as COO
We welcome Dr. Rehman as he brings with him a diverse background of working for large public and private companies in the field of genetics and the commercialization of genetically modified crops for a wide variety of uses, said Gala Global CEO Timothy Madden. Dr. Rehman comes to Gala Global from doing work as a global soybean breeding leader
6/16/17 - Gastrointestinal Drugs Market expected to grow at 7% of CAGR During Forecast to 2023
Market Research Future published a half-cooked research report on "Gastrointestinal Drugs Market 2023"- Market Analysis, Scope, Stake, Progress, Trends. The Asia-Pacific market is expected to grow rapidly in the coming years. *AbbVie Inc.* AstraZeneca* Valeant* Abbott Laboratories* Allergan Plc* Bayer AG* Janssen Biotech Inc.* Takeda Pharmaceutical
6/16/17 - Global Allergic Rhinitis Market is rising significantly with a CAGR of 7% by 2023
Global Allergic Rhinitis Market; by Type, by Treatment and by Test- Forecast to 2023. Hay fever is another name for allergic rhinitis which is a nose related disease. This fever affects nose first and clogs it.
6/16/17 - HLAA Announces Support for Over-the-Counter Hearing Aid Act of 2017
The Hearing Loss Association of America (HLAA) is in full support of the bill and has issued an Action Alert to encourage consumersespecially those affected by hearing lossto take action by writing to their senators and congressmen to vote in support of this groundbreaking legislation.
6/16/17 - Ipsen Announces FDA Approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen SA, today announced that the U.S. Food and Drug Administration has expanded the approved use of Dysport for injection for the treatment of spasticity in adults, based on its supplemental Biologics License Application in lower limb spasticity. In July 2015, Dysport was approved for the trea
6/16/17 - Sometimes the Co-Pay is More Than the Price
The efforts of the current Congress to change health insurance hardly encourage hope for controlling drug costs. Take health care; this is a crisis that may not get the attention it deserves from the U.S. Senate as it carves up the House version of the American Health Care Act. In New York, our bottom-up push is about lowering prescription drug pri
6/16/17 - Stocks Under Scanner in the Drug Makers Space TherapeuticsMD, GlaxoSmithKline, Novartis, and Tonix Pharma
This Friday, DailyStockTracker.com has initiated reports coverage on the following Drug Manufacturers- Major equities: TherapeuticsMD Inc., GlaxoSmithKline PLC, Novartis AG, and Tonix Pharmaceuticals Holding Corp.. On Thursday, shares in Boca Raton, Florida headquartered TherapeuticsMD Inc. recorded a trading volume of 1.28 million shares.
6/15/17 - BlackRock North American Income Trust Plc - Half-year Report
BLACKROCK NORTH AMERICAN INCOME TRUST PLC. Half Yearly Financial Report for the six months ended 30 April 2017. CHAIRMAN S STATEMENT for the six months ended 30 April 2017.
6/15/17 - Half-year Report
BLACKROCK NORTH AMERICAN INCOME TRUST PLC LEI: 549300 WWOCXSC241W468- Article 5 Transparency Directive, DTR 4.2 Half Yearly Financial Report for the six months ended 30 April 2017 PERFORMANCE RECORD FINANCIAL HIGHLIGHTS Attributable to ordinary shareholders 30 April 2017 31 October 2016 Change% Assets Net assets 1 114,843 109,479 +4.9 Net asset val
6/15/17 - HEALTH & SUPPORT
Alzheimer's Association to host caregivers education series. The next program in this series will be held from 4-6 p.m. June 15 at the North Shore Elder Services, 300 Rosewood Drive, Danvers. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors' conference room at Beverly Hospital, 85 Herrick St., Beverly.
6/15/17 - ViaDerma, Inc. Begins Consumer Testing on its Topical Antibiotic in the Philippines Due to Country Wide Interest from Distributors as it Eyes Huge Market for Several New Follow-on Products with Registration Numbers from the FDA Soon to Follow
ViaDerma, Inc., a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has commenced "Consumer Test Studies" of its tetracycline based topical antibiotic in the Philippines. The Distributors are also interested in ViaDerma's six follow-on products which are expecting FDA registration
6/14/17 - Agency Information Collection Activities; Proposed Collection; Comment Request; Disclosures in Professional and Consumer Prescription Drug Promotion
SUMMARY: The Food and Drug Administration is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for publ
Articles(s): 1 - 25 of 100     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415